Diagnosis and evaluation of prognosis of myelofibrosis: a British Society for Haematology Guideline
This document represents an update of the British Society for Haematology (BSH) guideline on myelofibrosis (MF) first published in 2012 and updated in 2015.1 This guideline aims to provide healthcare professionals with clear guidance on the diagnosis and prognostic evaluation of primary myelofibrosi...
Автори: | McLornan, DP, Godfrey, AL, Green, A, Frewin, R, Arami, S, Brady, J, Butt, NM, Cargo, C, Ewing, J, Francis, S, Garg, M, Harrison, C, Innes, A, Khan, A, Knapper, S, Lambert, J, Mead, A, McGregor, A, Neelakantan, P, Psaila, B, Somervaille, TCP, Woodley, C, Nangalia, J, Cross, NCP, McMullin, MF |
---|---|
Інші автори: | BSH Committee |
Формат: | Journal article |
Мова: | English |
Опубліковано: |
Wiley
2023
|
Схожі ресурси
Схожі ресурси
-
A guideline for the diagnosis and management of polycythaemia vera. A British Society for haematology guideline
за авторством: McMullin, M, та інші
Опубліковано: (2018) -
A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis
за авторством: McMullin, M, та інші
Опубліковано: (2018) -
Allogeneic stem cell transplantation for myelofibrosis in 2012.
за авторством: McLornan, D, та інші
Опубліковано: (2012) -
Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012.
за авторством: Reilly, J, та інші
Опубліковано: (2014) -
Guideline for the diagnosis and management of myelofibrosis.
за авторством: Reilly, J, та інші
Опубліковано: (2012)